Richard Bartram
CIK: 0001723729
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MBX
MBX Biosciences, Inc.
Officer
Discretionary Trading P&L
Holdings
About Bartram Richard
Bartram Richard (SEC CIK 0001723729) files insider reports with the SEC as Chief Financial Officer of MBX Biosciences, Inc. (MBX).
Signal8 holds 4 ownership filings by Bartram Richard (1 Form 3, 3 Form 4), filed between Sep 12, 2024 and Feb 3, 2026. Those filings report 3 transactions, from Sep 12, 2024 to Feb 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bartram Richard's filings is in CARMEL, IN.
Recent filings by Bartram Richard
Other insiders filing for MBX Biosciences, Inc. (MBX)
- Radovich Peter, Director
- Azoulay Salomon, Chief Medical Officer
- Smither John W, Chief Financial Officer
- Hoerter Steven L., President and CEO
- Mathers Edward T, Director
- Pescovitz Ora H., Director